US healthcare conglomerate UnitedHealth has exited Latin America with the sale of its last subsidiary in the region, hospital chain Empresas Banmedica, to Latino private equity firm Patria Investments.
Earlier this month reports showed Colombia’s already-struggling health system seeing units in hospitals in capital Bogotá being forced to close down to be able to continue other types of care services. In recent months patients have also been denied access to medications and health services, with the financial crisis facing the healthcare sector in the country still unfolding.
UAE-based Burjeel Holdings has joined forces with Colombian multinational Keralty in a cross-regional deal to establish a new healthcare enterprise aiming to deliver high-quality, affordable, and prevention-focused care.
Kidney dialysis services provider DaVita is going to become the largest dialysis services provider in Latin America following agreements with Fresenius Medical Care, a rival multinational group, to expand in Brazil and Colombia and enter Chile and Ecuador for the first time.
Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
Fresenius’ digital health subsidiary Curalie is reportedly up for sale, as the conglomerate’s CEO continues to win over investors, streamline the group, and replace management. Meanwhile HBI hears former Helios CEO Francesco De Meo may be unhappy with the circumstances of his departure - and could seek legal advice.
Fresenius Helios has a new CEO. Germany’s largest hospital group by revenue and subsidiary of Germany-based conglomerate Fresenius announced the news in a press release which ignores outgoing Francesco De Meo’s significant and longstanding contribution to the group.
This week, HBI looks at the annual inflow of nurses from abroad to the big five Western European markets - the United Kingdom, Germany, France, Italy, and Spain - using public data from OECD. Those looking for an outlier need look no further than the UK.
Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
HBI caught up with Norberto Jannuzzi, partner at Brazil based private equity group Patria Investimentos and 'Making smart investment choices' panelist at IFC’s Global Private Health Conference in Cape Town this week.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
